Articles From: Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types to Volcano Issues Statement Regarding Letter From Engaged Capital


Bristol-Myers Squibb Company (NYSE:BMY) and Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that they have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining Opdivo (nivolumab), Bristol-Myers Squibb’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, with FPA008, Five Prime’s monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R). The Phase 1a/1b study will evaluate the combination of Opdivo and FPA008 as a potential treatment option for patients with non-small cell lung cancer (NSCLC), melanoma, head and neck cancer, pancreatic cancer, colorectal cancer and malignant glioma.
Sign-up for Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types investment picks
PHILADELPHIA , Nov.
Sign-up for The Asia Tigers Fund, Inc. Announces Performance Data And Portfolio Composition investment picks
2014/11/10
BUENOS AIRES, Argentina , Nov.
Sign-up for Banco Macro Announces Results for the Third Quarter of 2014 investment picks
Zebra Technologies' Global Study Tracks the Growing Momentum of the Internet of Things in the Enterprise Businesses say IoT is the transformative technological initiative of the decade according to independent research Canada NewsWire LINCOLNSHIRE, Ill.
Sign-up for Zebra Technologies' Global Study Tracks the Growing Momentum of the Internet of Things in the Enterprise investment picks
Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”) is pleased to announce that, in connection with the Company’s recently closed offering of Series B Convertible Preferred Stock (“Preferred Stock”) and Warrants to purchase common stock (the “Warrants”), the underwriters have exercised their over-allotment option.
Sign-up for Wheeler Real Estate Investment Trust, Inc. Announces Exercise of Over-Allotment Option of Series B Preferred Stock and Warrants investment picks
LEXINGTON, Ky.
Sign-up for Alberta Health Services selects Lexmark for managed print services investment picks
Vishay Intertechnology, Inc. (NYSE: VSH) today introduced four new IGBT power modules designed specifically for string solar inverters and medium-power-range uninterruptible power supplies (UPS). Combining Ultrafast Trench IGBTs, high-efficiency HEXFRED ® and FRED Pt ® diode technologies, and thermistors for easy thermal management in single packages featuring pressfit technology, the Vishay Semiconductor modules offer complete integrated solutions for inverters based on 3-level neutral point clamp (NPC) topologies and interleaved multiple-channel MPPT (maximum power point tracking) boost converters.
Sign-up for New Vishay Intertechnology IGBT Power Modules Offer Complete Integrated Solutions for Solar Inverters and UPS investment picks
2014/11/7
http://media.marketwire.com/attachments/201204/36826_vista_logo.eps.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157197&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for Vista Partners Publishes November 2014 Macroeconomic & Investment Newsletter investment picks
http://media.marketwire.com/attachments/201205/45279_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157241&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for Media Alert: "Is Wi-Fi's Chaotic Nature Its Biggest Strength?" iPass CEO Evan Kaplan to Address This Question at Open Mobile Summit investment picks
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) and Bellicum Pharmaceuticals, Inc. today announced a restructuring of their license agreement for ARIAD’s cell-signaling technology.
Sign-up for ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology investment picks
2014/10/2
Today, Delaware Investments Dividend and Income Fund, Inc. (the “Fund”), a New York Stock Exchange–listed closed-end fund trading under the symbol “DDF,” declares a monthly dividend of $0.0525 per share.
Sign-up for Delaware Investments® Dividend and Income Fund, Inc. Announces Dividends investment picks
WWE (NYSE:WWE) announced that it will report its third quarter 2014 results on Thursday, October 30, 2014, before the opening of the market.
Sign-up for WWE® to Report Third Quarter 2014 Results investment picks
Monster (NYSE:MWW) in conjunction with the WageIndicator Foundation, today released data regarding wage disparities among men and women in the United States and Europe.
Sign-up for Staggering Wage Disparities between Men and Women across U.S. and Europe investment picks
2014/9/18
Argent Energy Trust confirms September 2014 distribution Canada NewsWire CALGARY , Sept.
Sign-up for Argent Energy Trust confirms September 2014 distribution investment picks
Jacobs Engineering Group Inc. (NYSE:JEC) announced today that Kevin Berryman is joining the company as Executive Vice President (EVP) and Chief Financial Officer (CFO). Mr.
Sign-up for Jacobs Appoints Kevin Berryman Executive Vice President and Chief Financial Officer investment picks
- Revenue of $39.4 Million, increase of 22% from Q3 2013 - Gross Sending Volume of $1.7 Billion, increase of 13% from Q3 2013 - 1,221,733 Active Customers, increase of 22% from Q3 2013 - CFO Ryno Blignaut stepping down; will be succeeded by VP of Finance Matt Hibbard SAN FRANCISCO, Oct.
Sign-up for Xoom Reports Third Quarter 2014 Results investment picks
2014/11/19
By Gillian Tan After repeated attempts by U.S. regulators to curb lending for debt-laden takeovers, Wall Street banks are still taking divergent views on whether they need to pass on potentially lucrative deals.
Sign-up for Regulators' Clarification Still Sows Banks' Unease investment picks
Integration of Lionbridge's Market-Leading Translation Services and Clay Tablet's Proven Technology Platform Provides a Seamless, Consistent Global Digital Experience for Clients Across End Markets WALTHAM, Mass.
Sign-up for Lionbridge Announces Acquisition Of Content Connectivity Software Firm Clay Tablet Technologies investment picks
2014/9/23
ATLANTA, Sept.
Sign-up for UPS Survey: Time to Act on Untapped Opportunities in Healthcare Industry investment picks
New Epicyn™ Hydrogel to be Introduced at Medica Trade Fair on November 12-15 in Dusseldorf, Germany ROERMOND, Netherlands and PETALUMA, Calif., Nov.
Sign-up for Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Scar Management Hydrogel investment picks
Revolution Lighting Technologies, Inc. (NASDAQ:RVLT) (“Revolution Lighting”), a global provider of advanced LED lighting solutions, today announced that it has filed a universal shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission.
Sign-up for Revolution Lighting Technologies Files Universal Shelf Registration Statement investment picks
Iao Kun Group Holding Company Limited (“IKGH” or the “Company”) (NASDAQ:IKGH), which operates through its subsidiaries and related promotion entities that act as VIP room gaming promoters and collaborator, previously announced that its Board of Directors had authorized a regular dividend each year after the release of the Company’s financial results for the six months ending June 30 (the “Six Month Dividend”). The Board of Directors previously reduced the Six Month Dividend from $0.08 per share to $0.026 per share beginning with the Six Month Dividend payable for 2014.
Sign-up for Iao Kun Group Holding Company Limited Announces Record Date and Payment Date of 2014 Six Month Cash Dividend investment picks
2014/12/5
By Jennifer Booton, MarketWatch NBC's "Peter Pan" pulls in half the viewers of "The Sound of Music" NEW YORK (MarketWatch)--NBC may have high hopes for live theater in the future of broadcast television, but a flop of its live rendition of "Peter Pan" Thursday night might change its mind.
Sign-up for UPDATE: "Peter Pan" not the hook NBC was hoping for investment picks
2014/10/8
Romarco reaches agreement with conservation groups for Haile Gold Mine Canada NewsWire TRADING SYMBOL: TSX: R TORONTO , Oct.
Sign-up for Romarco reaches agreement with conservation groups for Haile Gold Mine investment picks
Renowned Nephrologist to Head Up Hospital Services Group DENVER , Oct.
Sign-up for Dr. John Wigneswaran Joins Team at DaVita Kidney Care investment picks
SAN DIEGO , Sept.
Sign-up for Volcano Issues Statement Regarding Letter From Engaged Capital investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types to Volcano Issues Statement Regarding Letter From Engaged Capital
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent